// you're reading...

News

MilleGen – a biotech in Toulouse aim to clone IC2

A consortium consisting of University of Copenhagen, MilleGen in Toulouse and Stanford University collaborate on the DNA clone IC2 and create fusion-proteins for optical in vivo imaging.

Welcome to ImmunoSigns

ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.

The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.

Shopping Cart